Chemotherapy, radiotherapy (for rectal cancer), biologic agents (anti-VEGF or anti-EGFR antibody), targeted therapy and immunotherapy also play important roles in the systemic treatment of CRC patients 2. The gene discussed is EGFR; the disease is colorectal carcinoma.